Naphazoline (Preferred Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Naphazoline drug offered from Preferred Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Preferred Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Naphazoline Hydrochloride
SUBSTANCE NAME: NAPHAZOLINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-04-22
END MARKETING DATE: 0000-00-00


Naphazoline HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNaphazoline from Preferred Pharmaceuticals, Inc.
LABELER NAME: Preferred Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2013-04-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68788-9680_918d7204-1fc1-4f89-87b7-4564f0eabfa6
PRODUCT NDC: 68788-9680
APPLICATION NUMBER: ANDA083590

Other NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Naphazoline
Insight PharmaceuticalsPrivine
Insight Pharmaceuticals LLCPrivine
International Nature NutraceuticalsPi Yen Chin
Preferred Pharmaceuticals, Inc.AK-Con
Proficient Rx LPNaphazoline
Rebel Distributors Corp.AK-Con
Sato Pharmaceutical Co., Ltd.Sato Clear